CY1109209T1 - Μητρες ανιονικης υδρογελης με ph-εξαρτωμενη τροποιημενη αποδεσμευση ως μεταφορεις φαρμακων - Google Patents

Μητρες ανιονικης υδρογελης με ph-εξαρτωμενη τροποιημενη αποδεσμευση ως μεταφορεις φαρμακων

Info

Publication number
CY1109209T1
CY1109209T1 CY20091100701T CY091100701T CY1109209T1 CY 1109209 T1 CY1109209 T1 CY 1109209T1 CY 20091100701 T CY20091100701 T CY 20091100701T CY 091100701 T CY091100701 T CY 091100701T CY 1109209 T1 CY1109209 T1 CY 1109209T1
Authority
CY
Cyprus
Prior art keywords
modified release
medicines
motors
transport
anionic hydrogel
Prior art date
Application number
CY20091100701T
Other languages
English (en)
Inventor
Gaetano Giammona
Delia Mandracchia
Original Assignee
Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. filed Critical Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Publication of CY1109209T1 publication Critical patent/CY1109209T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)

Abstract

Περιγράφονται συνθέσεις με ph-εξαρτώμενη τροποποιημένη απευλευθέρωση, που αποτελούνται από μήτρες υδρογέλης οι οποίες περιέχουν ένα ή περισσότερα ενεργά συστατικά ενεργά, μέσα στις οποίες οι αναφερόμενα μήτρες είναι κατάλληλες για την απελευθέρωση των αναφερόμενων ενεργών συστατικών με παρατεταμένο τρόπο μέσα σε καθορισμένους χώρους του σώματος.
CY20091100701T 2004-04-01 2009-07-03 Μητρες ανιονικης υδρογελης με ph-εξαρτωμενη τροποιημενη αποδεσμευση ως μεταφορεις φαρμακων CY1109209T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000168A ITRM20040168A1 (it) 2004-04-01 2004-04-01 Composizione a rilascio modificato ph dipendente.
EP05718991A EP1729732B1 (en) 2004-04-01 2005-02-16 Anionic hydrogel matrices with ph dependent modified release as drug carriers

Publications (1)

Publication Number Publication Date
CY1109209T1 true CY1109209T1 (el) 2014-07-02

Family

ID=34961555

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20091100701T CY1109209T1 (el) 2004-04-01 2009-07-03 Μητρες ανιονικης υδρογελης με ph-εξαρτωμενη τροποιημενη αποδεσμευση ως μεταφορεις φαρμακων

Country Status (20)

Country Link
US (1) US20070166383A1 (el)
EP (1) EP1729732B1 (el)
JP (1) JP2007530666A (el)
KR (1) KR20060133578A (el)
CN (1) CN1913875B (el)
AT (1) ATE428405T1 (el)
AU (1) AU2005228716B2 (el)
BR (1) BRPI0509475A (el)
CA (1) CA2551797A1 (el)
CY (1) CY1109209T1 (el)
DE (1) DE602005013935D1 (el)
DK (1) DK1729732T3 (el)
ES (1) ES2325626T3 (el)
HR (1) HRP20090329T1 (el)
IT (1) ITRM20040168A1 (el)
PL (1) PL1729732T3 (el)
PT (1) PT1729732E (el)
RS (1) RS51178B (el)
SI (1) SI1729732T1 (el)
WO (1) WO2005094792A1 (el)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4746883B2 (ja) * 2005-01-28 2011-08-10 リンテック株式会社 ハイドロゲル基剤、パップ剤基剤、パップ剤及び水性ゲルシート
JP5833450B2 (ja) 2008-12-31 2015-12-16 スリーエム イノベイティブ プロパティズ カンパニー 微小粒子を用いた生きた生物負荷の検出法
EP2379697A2 (en) 2008-12-31 2011-10-26 3M Innovative Properties Company Sampling devices and methods for concentrating microorganisms
US9284593B2 (en) 2009-12-30 2016-03-15 3M Innovative Properties Company Live bioload detection using microparticles
WO2011082258A2 (en) 2009-12-30 2011-07-07 Regents Of The University Of Minnesota Bone cement and method
KR101228106B1 (ko) * 2010-01-21 2013-02-01 광주과학기술원 피부투과도, 세포유입 및 종양전달성이 증가된 나노운반체
WO2011090349A2 (ko) * 2010-01-21 2011-07-28 광주과학기술원 피부투과도, 세포유입 및 종양전달성이 증가된 나노운반체
CN103330702B (zh) * 2013-07-02 2016-03-02 江苏长泰药业有限公司 含有拟交感神经胺盐和诱导凝胶体系的医药组合物
CN108452291A (zh) * 2018-07-04 2018-08-28 西南大学 用天然丝胶蛋白治疗溃疡性结肠炎的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4071508A (en) * 1975-02-11 1978-01-31 Plastomedical Sciences, Inc. Anionic hydrogels based on hydroxyalkyl acrylates and methacrylates
IT1284661B1 (it) * 1996-06-06 1998-05-21 Sigma Tau Ind Farmaceuti Uso di alcanoil l-carnitine nel trattamento terapeutico di malattie infiammatorie croniche intestinali.
DE19653631A1 (de) * 1996-12-20 1998-06-25 Basf Coatings Ag Verfahren zum Herstellen von durch Strahlung vernetzbaren polymeren Acryl- oder Methacrylsäureestern
WO1998055161A1 (en) * 1997-06-03 1998-12-10 Innogenetics N.V. New medicaments based on polymers composed of methacrylamide-modified gelatin
MXPA01007844A (es) * 1999-02-03 2005-06-06 Powderject Res Ltd Formulaciones de particulas en hidrogel.
US6547182B2 (en) * 2001-07-19 2003-04-15 Aerojet-General Corporation Solid rocket motor bolted thrust takeout structure
US7204997B2 (en) * 2002-01-29 2007-04-17 Supratek Pharma Inc. Responsive microgel and methods related thereto

Also Published As

Publication number Publication date
PL1729732T3 (pl) 2009-09-30
JP2007530666A (ja) 2007-11-01
DK1729732T3 (da) 2009-08-10
KR20060133578A (ko) 2006-12-26
PT1729732E (pt) 2009-07-02
US20070166383A1 (en) 2007-07-19
CN1913875A (zh) 2007-02-14
RS51178B (sr) 2010-10-31
ES2325626T3 (es) 2009-09-10
DE602005013935D1 (de) 2009-05-28
AU2005228716B2 (en) 2010-07-15
EP1729732A1 (en) 2006-12-13
SI1729732T1 (sl) 2009-08-31
CA2551797A1 (en) 2005-10-13
BRPI0509475A (pt) 2007-09-11
HRP20090329T1 (en) 2009-09-30
CN1913875B (zh) 2011-08-31
AU2005228716A1 (en) 2005-10-13
ATE428405T1 (de) 2009-05-15
EP1729732B1 (en) 2009-04-15
WO2005094792A1 (en) 2005-10-13
ITRM20040168A1 (it) 2004-07-01

Similar Documents

Publication Publication Date Title
CY1109209T1 (el) Μητρες ανιονικης υδρογελης με ph-εξαρτωμενη τροποιημενη αποδεσμευση ως μεταφορεις φαρμακων
CY1114769T1 (el) Διασπαρσιμα στο νερο αγροχημικα σκευασματα που αποτελουνται απο πολυαλκοξυτριγλυκεριδια ως υποκινητες διεισδυσης
MX2009006917A (es) Agentes para combatir parasitos en animales.
TW200800967A (en) Benzimidazole thiophene compounds
EP2308867A3 (en) 2-oxo-1-pyrrolidine deriatives, processes for preparing them and their uses
MXPA05007328A (es) Composiciones que contienen agentes antiacne y el uso de las mismas.
EP2350252A4 (en) ANTIMICROBIAL FOAMABLE SOAPS
CR11167A (es) Uso de homo y copolimeros para la estabilizacion de formulaciones de principios activos
TR201911270T4 (tr) Polimerik mirsen bileşimleri.
TW200633716A (en) Compositions and methods for stabilizing active pharmaceutical ingredients
TW200716605A (en) 2,6-quinolinyl derivatives, processes for preparing them and their uses
WO2008066630A3 (en) Methods for reprogramming adult somatic cells and uses thereof
CR9114A (es) 2-alcoxi-3,4,5-trihydroxi-alquimidas, su preparacion composicones que las contienen y su utilizacion
TW200508197A (en) Indolone-acetamide derivatives, processes for preparing them and their uses
MX2009011493A (es) Complejo de excipiente farmaceutico.
UA100850C2 (ru) Средство для борьбы с паразитами на животных
TW200613003A (en) Active compound-containing solid moulded bodies for external use against parasites on animals
EA200601596A1 (ru) Улучшенный состав 6-меркаптопурина
PL376130A1 (en) Controlled releases system containing temozolomide
UY28812A1 (es) Agente parasiticida
TNSN07438A1 (en) Prolonged release formulation of active principles having a ph-dependent solubility
TW200610526A (en) Novel hydrophilic analogs of 4,8-dihydrobenzodithiophene-4,8-diones as anticancer agents
CY1110089T1 (el) 2-αλκοξυ-3,4,5-τριϋδροξυ-αλκυλαμιδο-βενζοθειαζεπινη, η παρασκευη τους, σε ποιες συνθεσεις περιεχονται και η χρηση τους
DOP2004000826A (es) Nuevas composiciones antihelminticas e insecticidas
UY28199A1 (es) Nuevas composiciones antihelmínticas e insecticidas